HealthStream, Inc. (NASDAQ: HSTM) authorized a new share repurchase program on March 13 2026, allowing the company to buy up to $10 million of its common stock from the open market, including through Rule 10b‑5 plans. The program represents a new financing action that had not been disclosed previously.
The authorization follows a recent history of buybacks: a $10 million program approved in November 2025, of which $5 million was repurchased in Q4 2025 and the remainder in January 2026; a $25 million program completed in Q3 2025. The new program continues this strategy of returning capital to shareholders while supporting the stock price.
In conjunction with the buyback, HealthStream amended its credit facility with Truist Bank, granting greater flexibility for restricted payments—including dividends and share repurchases—provided the company maintains a pro‑forma leverage ratio below 1.50:1.00. This amendment signals a more shareholder‑friendly financial policy.
The buyback decision is underpinned by strong Q4 2025 earnings: revenue reached $79.7 million, up 7.4% year‑over‑year and exceeding the consensus estimate of $77.7 million; non‑GAAP earnings per share were $0.18, beating the $0.13 estimate by 38.46%; and adjusted EBITDA rose 16.4% to $18.8 million. Management highlighted record quarterly revenue and the company’s positioning in the AI‑driven healthcare workforce market.
The program will terminate on the earlier of September 12 2026 or when the $10 million limit is reached. The board also approved a quarterly cash dividend of $0.035 per share, a 12.9% increase, reflecting confidence in ongoing cash generation.
Together, the share repurchase program, credit facility amendment, and robust earnings underscore HealthStream’s confidence in its long‑term growth prospects and its ability to generate strong cash flow, providing additional capital return to shareholders.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.